MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Post-stroke Movement Disorders: A Systematic Review of the Clinical Spectrum, Neuroanatomy, and Demographic Characteristics of 577 Published cases

    B. Mishra, A. Agarwal, M. Nayak, N. Nilima, P. Srivastava, V. Vishnu (South delhi, India)

    Objective: To comprehensively examine the spectrum of post-stroke movement disorders (PSMDs), with a focus on understanding their prevalence, clinical characteristics, neuroanatomical correlates, and demographic profiles…
  • 2024 International Congress

    Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.

    C. álvarez-Hernández, R. Baños-Betancourt, K. Velazquez-Roman, G. Rivera-Monroy, A. Guerra-Anzaldo, W. Moguel-Cardín, A. Domínguez-García, D. Romero-Terán, A. Regalado-Mustafá, J. Delgado-Uriarte, N. Moreno-Aldama, A. Uribe Leon, M. Unda-Mcfarlane, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Luna-Escamilla, K. Gonzalez-Rosas, U. Ugalde-Miranda, F. Moralez-Gonzalez, M. Cabrera-Jimenez (Mexico City, Mexico)

    Objective: To determine the degree of motor and postural impairment of patients with Parkinson's Disease at the time of their first consultation according to the…
  • 2024 International Congress

    Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

    P. Hoff, F. Butt (Oklahoma City, USA)

    Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…
  • 2024 International Congress

    Parkinson Disease. An innovative Aproach

    M. Martinovic, G. Montado, R. Aljanati (Montevideo, Uruguay)

    Objective: Aims: promoting maximum autonomy, potentiating resources, improve functionality, stimulating activity, preventing complications. Background: Since 2006, the Program has operated uninterruptedly, even during COVID-19. Aimed…
  • 2024 International Congress

    New onset movement disorders following COVID-19 infection

    D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

    Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…
  • 2024 International Congress

    PKG-Ethnicity project: An initial analysis of ethnical differences in Parkinson’s KinetoGraph (PKG) results between white and non-white ethnic groups

    MA. Qamar, L. Batzu, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

    Objective: Using the Parkinson’s KinetiGraph (PKG) reports of PwP to determine if scores vary according to ethnicity, classed as white or non-white PwP (Black, Asian,…
  • 2024 International Congress

    Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

    N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

    Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
  • 2024 International Congress

    Assessing Feasibility of Using Phone Video Data in Diagnosing Parkinsonism

    Z. Ahmed, S. Desai, A. Deb, S. Roy, D. Desai (Worcester, USA)

    Objective: This project aims to address potential gaps in rural healthcare by assessing the feasibility of using mobile phone data to identify features of parkinsonism…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

    S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley